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Abstract. Cervical carcinoma is frequently diagnosed among 
women, particularly in low and middle income countries. In 
this study, we investigated the role of the SDF-1/CXCR4 axis 
during cervical carcinoma growth and progression in vitro and 
in vivo. Downregulation of CXCR4 receptor using an RNA 
interference system led to almost complete inhibition of the 
receptor expression, activation and function. CXCR4 receptor 
silencing led to decreased ability to signal, to induce migra-
tion and to form holoclone-like colonies, with no influence 
on viability/proliferation of the cells. CXCR4-deficient cells 
had also significantly lower levels of MMP-9. Interestingly, 
downregulation of CXCR4 expression resulted in reduced 
tumor growth in vivo. Tumors generated by CXCR4-deficient 
cells had also lower expression of the proliferation marker 
Ki-67 and decreased ability to engraft into lungs and spleen. 
Taken together, our results indicate that CXCR4 receptor may 
play an important role during cervical carcinoma invasion. In 
our study CXCR4 influenced invasive properties of cervical 
carcinoma cells both in vitro and in vivo.
Introduction
CXCR4 is a seven-span transmembrane G-protein coupled 
receptor for SDF-1 (stromal derived factor-1). The interaction 
between SDF-1 and its receptor CXCR4 activates multiple 
biological processes e.g. organogenesis and hematopoiesis, 
migration, proliferation, adhesion, inflammation and plays a 
critical role during tumor growth and metastasis (1-4). SDF-1 - 
CXCR4 axis has been shown to direct tumor cells to organs 
that highly express SDF-1 e.g., lymph nodes, lungs, liver or 
bones (5-7). It was also shown that cells expressing CXCR4 
are clonally selected during their growth in the mammary fat 
pad of nude mice. A further increase in CXCR4 expression, 
and SDF-1-mediated migration was observed in cancer cells 
that metastasized to the lungs (8). Furthermore, blockade of 
CXCR4 inhibits tumor growth in a mouse model (9).
CXCR4 receptor is involved in a multistage process of 
metastasis (10,11). Scientific reports clearly indicate a signifi-
cant role of CXCR4 receptor in breast, prostate, ovarian or 
melanoma cancer progression (12,13). In addition, CXCR4 
tumor positive cells are characterized by high self-renewal 
abilities, tumor initiation and resistance to treatment (11,14). 
The ability of cancer cells to spread throughout the body is 
dependent on the interactions of their cell surface molecules 
with the microenvironment and the presence of cancer stem 
cells (CSCs) (11,15). CSCs initiate primary tumor growth, 
have the ability to self-renew and give rise to more differenti-
ated cell types. They participate in cancer cell migration to 
distant tissue where they are able to form secondary tumor 
from a single cell (11,16). CSCs are very difficult to identify 
but recognition of them seems to be necessary for efficient 
cancer treatment. Their resistance to chemo- and radiotherapy 
is an additional exertion to elaborate relevant anticancer 
targeted therapy. Many of CSC markers are still unrecognized. 
Moreover, their expression profile may be addicted to the 
origin and type of the tumor. As previously described, CSCs 
demonstrate high expression of the CXCR4 receptor (17).
Cervical carcinoma (CC) is highly associated with human 
papillomavirus (HPV) infection that is one of the major risk 
factor for CC development. At early stages, CC cells occupy 
the surrounding tissue whereas in advanced stages they 
migrate and form metastases in regional lymph nodes, bone 
marrow, lungs, spleen and liver (18-20). However, despite the 
development of vaccine against HPV infection, cervical carci-
noma is one of the most frequently diagnosed tumor among 
women with no available effective therapy at advanced stages.
Downregulation of gene expression is the appropriate 
method to evaluate the role of genes of interest (21,22). In our 
study we efficiently blocked CXCR4 gene expression with 
lentivirus shRNA construct directed against the CXCR4 gene 
and investigated the role of CXCR4 receptor in CC develop-
ment and metastasis.
Materials and methods
Cell culture. HTB-35 cell line was purchased from ATCC 
(Rockville, MD, USA) and maintained in culture medium 
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MEM (minimal essential medium, PAA Laboratories GmbH) 
supplemented with 10% heat-inactivated FBS (Fetal Bovine 
Serum, PAA) and 0.05 mg/ml gentamycin (PAA). Cells were 
cultured in a humidified atmosphere at 5% CO2 and 37˚C. 
They were split usually twice a week.
Lentiviral transduction. HTB-35 cells were transduced with 
Fusin shRNA Lentiviral Particles (Santa Cruz Biotechnology, 
Santa Cruz, CA, USA) in 6 µg/ml polybrene (Sigma, St. 
Louis, MO, USA) according to the manufacturer's protocol. 
Transduced cells were selected with 2.5 µg/ml puromycin 
(InvivoGen, San Diego, CA, USA) for 16 days. Next, the cell 
line was analyzed to confirm the reduction of CXCR4 gene 
expression at the mRNA and protein level and subjected to 
further characterization. For control cell line, HTB-35 cells 
were transduced with Control shRNA Lentiviral Particles 
(Santa Cruz Biotechnology) as described above.
Flow cytometry. Extracellular staining of CXCR4 receptor 
was tested by flow cytometry. Cells were split with non-
enzymatic Cell Dissociation Solution (Sigma). Cells (1x105) 
in 90 µl staining buffer (PBS supplemented with 2% FBS) 
were added to a test tube containing the appropriate amount of 
monoclonal PE-conjugated mouse anti-human CD184 antibody 
(clone 12G5, BD Bioscience-Pharmingen, San Jose, CA, USA). 
Isotype-matched mouse PE-conjugated immunoglobulin 
(IgG2aĸ) served as control (clone G155-178, BD Pharmingen, 
San Jose, CA, USA). After 30 min of incubation on ice in 
the dark, cells were washed with staining buffer twice and 
collected using a FACSCanto cytometer (Becton-Dickinson, 
San Jose, CA, USA). Data were analyzed with FACS Diva 
(Becton-Dickinson), WIN MDI 2.9 (free program available) 
and Cyflogic v.1.2.1. software (free program available).
Quantitative real-time PCR (qRT-PCR) analysis. The total RNA 
isolation was performed using RNeasy Mini kit (Qiagen, Hilden, 
Germany). followed by DNAse treatment (Promega, Madison, 
WI, USA). RNA (1 µg) was used for the reverse transcriptase 
reaction that was carried out using M-MLV reverse transcriptase 
(Promega) according to the manufacturer's protocol. qRT-PCR 
analysis was performed on ABI PRISM 7300 Sequence 
Detection System (Applied Biosystems, Inc., Foster City, CA, 
USA) using TaqMan Gene Expression Master MiX (Applied 
Biosystems, Inc.). Probes used in this study were as follows: 
human GAPDH (Hs99999905_m1), MMP9 (Hs00234579_m1), 
TIMP1 (Hs00171558_m1), TIMP2 (Hs00234278_m1), HIF-1α 
(Hs00153153_m1), VEGF (Hs00900055_m1) and mouse 
GAPDH (Mm99999915_g1). The mRNA expression level was 
normalized to the housekeeping gene GAPDH. The experiments 
were performed three times in duplicate. Data are presented as 
% of control cells (wild-type).
MTS assay. To examine mitochondrial activity of tumor cells 
MTS test was done. Cells (2x103) were seeded on 96-well 
plates. Analysis was performed in two different conditions: 
culture medium supplemented with FBS (MEM 10% FBS) 
and culture medium supplemented with bovine serum albumin 
(MEM 0.5% BSA). After 24, 48, 72 and 96 h CellTiter 96® 
AQueous One Solution assay (Promega) was added according 
to the manufacturer's protocol. After 2 h the level of absor-
bance was read at a wavelength of 490 nm using the ELx800 
Universal Microplate Reader (BioTek Instruments, Highland 
Park, USA) and analyzed with KC4 v3.0 with PowerReports 
software. The results are presented as mean absorbance value 
in an appropriate time. The experiment was carried out three 
times in triplicates.
Colony-forming assay. To determine different colony morpho-
logies, 1x103 cells were plated as a single cell on a 6-well 
plate in culture medium. As a colony, we recognized a cluster 
consisting of at least 6 cells. After 4 days different colony 
morphologies were observed. Paraclone-, holoclone- and 
meroclone-like colonies were identified. Colonies were fixed, 
stained using Wright's reagent (Merck, Darmstadt, Germany) 
and counted in 10 fields at x100 magnification under a light 
Olympus BX-51 microscope. Two independent experiments 
were performed. The percentage of paraclone- and holoclone- 
like colonies recognized as a result of cell culture in low 
density ± D are presented.
Suspension growth assay. Cells were seeded at a density of 
3x104 on a non-adherent 24-well plate (Thermo Scientific, 
Rockford, IL, USA) in culture medium for 48 h at 37˚C and 
5% CO2. After this time cells were collected and seeded at 
1x103 on a 6-well plate in order to observe the clonal growth 
potential and in the amount of 2x103 on a 96-well plate to 
determine the mitochondrial activity potential (MTS assay). 
Experiments were performed two times according to the 
schemes described above.
Cell stimulation. Cells (2.5x105) were seeded on 6-well plates 
in culture medium. The next day, culture medium was changed 
to MEM 0.5% BSA to make cells quiescent. Stimulation 
was performed with SDF-1β (100 ng/ml) (PeproTech, Rocky 
Hill, NJ, USA) for 2, 5, 10 and 30 min. Medium containing 
10% FBS and 0.5% BSA were positive and negative control, 
respectively.
Western blot analysis. Cells were lysed (for 10 min) on ice in 
M-Per lysing buffer (Pierce) containing protease and phospha-
tase inhibitors (Sigma). Protein concentration was determined 
by Bradford protein assay. Protein samples [containing 20 μg 
of protein, LDS (NuPage LDS sample buffer; Invitrogen Life 
Technologies, Carlsbad, CA, USA), Bond Breaker (Thermo 
Scientific) and M-Per buffer] were separated on a 12% sodium 
dodecyl sulfate-PAGE gel and transferred into a PVDF 
membrane (Bio-Rad Laboratories, Hercules, CA, USA). The 
phosphorylation of AKT and MAPK was assessed using 
primary rabbit anti-phospho-AKT (Ser 473, Cell Signaling, 
Danvers, MA, USA) and primary mouse anti-phospho-MAPK 
(Thr202/Tyr204, Cell Signaling) antibodies and subsequently 
detected with horseradish peroxidase (HRP)-conjugated goat 
anti-rabbit IgG secondary antibody (sc-2054; Santa Cruz 
Biotechnology) and (HRP)-conjugated goat anti-mouse IgG 
secondary antibody (sc-2055; Santa Cruz Biotechnology). 
The membranes were developed with an enhanced chemi-
luminescence reagent (ECL, Amersham Life Sciences, 
Buckinghamshire, UK) dried and subsequently exposed to 
the HyperFilm (Amersham Life Sciences) or imaged by Gel 
Logic Imaging System 1500 (Kodak; Molecular Imaging 
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System, New Haven, CT, USA). An equal loading in the lanes 
was evaluated by probing with anti-rabbit monoclonal anti-
GAPDH antibody (14C10; Cell Signaling). The experiment 
was performed two times with similar results. Representative 
data are presented.
Chemotaxis assay. To check the tumor cells the migration 
ability towards SDF-1β gradient, modified Boyden's chamber 
with 8-µm pore polycarbonate membrane inserts (Costar 
Transwell; Costar-Corning, Lowell, MA, USA) were used. 
Cells were harvested with non-enzymatic Cell Dissociation 
Solution (Sigma). Cell suspension at the density of 3x104 in 
100 µl MEM 0.5% BSA was placed in the upper chamber of the 
insert. In the lower chamber 650 µl medium contained SDF-1β 
[100 ng/ml] was placed. After 24-h incubation in a humidified 
atmosphere at 5% CO2 and 37˚C the transmigrated cells were 
fixed, stained with Wright solution (Merck) and counted in five 
fields of view at x100 magnification using an inverted light 
microscope (Olympus IX70). Medium containing 10% FBS, or 
0.5% BSA was the positive and negative control, respectively. 
Experiment was performed two times in duplicates.
In vivo tumor models (animal experiments). The 6- to 8-week 
old male NOD-SCID mice (non-obese diabetes severe combined 
immunodeficiency mice) were used to evaluate the in vivo meta-
static behavior of tumor cells.
Subcutaneous injection: mice were injected with 5x106 tumor 
cells/mouse. Twice a week the volume of primary tumors was 
quantified using the formula [(x2y)/2] for an ellipsoid. After 
30 days mice were subjected to anesthesia, tumors were weighed 
and fixed in 10% formalin. Immunohistochemical evaluation 
was prepared using hematoxylin and eosin staining and primary 
mouse monoclonal antibodies anti-Ki-67 (clon MIB-1; 1:75, 
Biocompare, DakoCytomation, Glostrup, Denmark).
Intravenous injection: mice were injected through the 
eyeball with 1x106 tumor cells per mouse for 24 h and 30 days. 
After this time, mice were sacrificed. Isolation of bone marrow 
was performed. Organ tissues such us lungs and spleen was 
isolated and homogenized using Cell Strainer (BD Bioscience) 
with a 40-micron pore size. To assess the potential sites of 
metastasis, RNA isolation, reverse transcription and qPCR 
(as previously described) was performed to define human to 
mouse GAPDH proportion.
Animal experiments were approved by the Local Ethics 
Committee for Experiments on Animals acting at the Jagiellonian 
University in Krakow (Resolution No. 56/2011). Two independent 
experiments were carried out with 10 NOD-SCID mice/group.
Statistical analysis. Statistical analysis was performed using 
Statistica v10 software by one-way ANOVA and the Tukey 
test. The results with P-values <0.05 were considered as statis-
tically significant, and labeled by an asterisk in the figures.
Results
Downregulation of CXCR4 gene expression. In order to effi-
ciently knock down the CXCR4 gene expression, HTB-35 cell 
line was transduced with Fusin shRNA lentiviral particles, and 
shRNA lentiviral particles were used as a control. After trans-
duction and antibiotic selection, we obtained 80% and 90% 
reduction of CXCR4 gene expression at mRNA and protein 
level, respectively, compared to control cells: wild-type (WT) 
and shCONTROL (Fig. 1A and B).
Figure 1. The confirmation of CXCR4 gene downregulation. Transduction 
with fusin shRNA lentiviral particles obtained 80% reduction of CXCR4 
expression at mRNA level [(A) real-time PCR] and 90% reduction of CXCR4 
at protein level [(B) FACS analysis]. (C) The expression of phospho-AKT and 
phospho-MAPK after human SDF-1β (100 ng/ml) stimulation of control cells 
(HTB-35 WT and HTB-35 shCONTROL) and examined the cells (HTB-35 
shCXCR4) at 2, 5, 10 and 30 min. Strong phosphorylation of AKT and 
MAP kinases after 5 min stimulation in control cells was observed. CXCR4 
receptor downregulation resulted in lower phosphorylation level of the 
examined pathways. Medium containing 10% FBS or 0.5% BSA consisted of 
positive and negative control, respectively. GAPDH was used as a control of 
equal loading. The experiment was performed two times with similar results. 
Representative data are presented. (D) The significant reduction of shCXCR4 
cell migration potential towards SDF-1β gradient (100 ng/ml) compared 
to control cells (HTB-35 WT and HTB-35 shCONTROL) was observed in 
chemotaxis assay; *P<0.05, ±SD.
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Next, we examined the effectiveness of the CXCR4 gene 
knockdown. Western blot analysis showed strong phosphoryl-
ation of AKT and MAPK kinases after 5 min stimulation 
in control cells. The shCXCR4 cells also responded to the 
chemokine but at a lower level. The weak stimulation might be 
caused by CXCR7 receptor activity, the second SDF-1 receptor 
(Fig. 1C). Moreover, downregulation of CXCR4 receptor led 
to almost 7-fold decrease in the chemotactic activity toward 
SDF-1β gradient compared to control cells (Fig. 1D).
CXCR4 receptor maintains the diversity of clonal 
morphology. The epithelial origin of HTB-35 cell line is 
associated with the capacity to form colony-like structures as 
a result of culture beginning at low density. In order to analyze 
whether the CXCR4 receptor is involved in the diversity of 
clonal morphology, colony-forming assay was used. After 
6-day culture at low density, ʻholocloneʼ-, ʻmerocloneʼ- and 
ʻparaclone -̓like colonies were identified (Fig. 2A). Our results 
suggest that CXCR4 receptor downregulation increases the 
number of ʻparaclone -̓like colonies in comparison to control 
cells (Fig. 2B). Cell culture under the suspension condition for 
48 h has no influence on the colony formation but changes the 
percentage participation of different types of colonies. Control 
cell lines had lost cells which are able to form ʻparaclone -̓like 
colonies. Similar effect was observed in shCXCR4 cells where 
the percentage of ʻparacloneʼ-like colonies decreased about 
50% compared to control condition (Fig. 2C). Furthermore, 
growth in suspension has no influence on mitochondrial 
activity of examined cells (Fig. 2D).
CXCR4 receptor modulates the expression of MMP-9. To 
evaluate if CXCR4 receptor mediates the expression of genes 
related to angiogenesis and metastasis, quantitative real-time 
RT-PCR was performed. We observed significant positive 
correlation between CXCR4 and matrix metalloproteinase 
(MMP-9) level. CXCR4 downregulation resulted in the 
reduction of MMP-9 and had no influence on tissue matrix 
metalloproteinase inhibitor-2 (TIMP-2) expression. In HTB-35 
cell line, the interaction at mRNA level between CXCR4 and 
hypoxia-inducible factor 1-α (HIF-1α) or vascular endothelial 
growth factor (VEGF) was not observed (Fig. 3).
CXCR4 downregulation does not influence the cell prolifer­
ation rate in vitro but efficiently reduces tumor growth and 
metastasis in a murine model in vivo. The effect of CXCR4 
downregulation on HTB-35 tumor cell proliferation rate 
was measured by MTS assay. Cells were cultured for 96 h 
in medium supplemented with 0.5% BSA or 10% FBS. We 
observed no differences in the proliferation rate between 
shCXCR4 cells and control cells either under starvation or 
control conditions (Fig. 4).
Interestingly, the results from in vitro tests were different 
from in vivo results. Our studies showed that CXCR4 down-
regulation reduces HTB-35 cell growth and metastasis. 
Subcutaneous injection with shCXCR4 cells in NOD-SCID 
mice was associated with a significant decrease (about 30%) 
in tumor growth potential (Fig. 5A and B) compared to control 
cells. In addition, Ki-67 staining showed decreased prolifera-
tion activity in tumors formed by shCXCR4 cells (Fig. 5C). 
Figure 2. Colony-forming assay resulted in diversity of clonal morphology after culture at low density. (A) Colony morphology was observed as holoclone-
like colony structures with stem cell characteristic and paraclone-like colony structures formed by differentiated cells. (B) After 48-h growth at suspension 
condition mitochondrial activity was checked. We observed no differences in MTS assay between examined and control cells (B). Culture conditions (C) and 
suspension conditions (D) lead to increased number of paraclone-like colonies depending on the decrease of CXCR4 level. The experiment was carried out two 
times in triplicates. Data are presented as mean optical density (OD) ± SD at the appropriate time.
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However, H&E staining revealed no differences between 
morphology of the tumors formed by shCXCR4 cells and 
control cells (Fig. 5C).
Intravenous injection demonstrated the participation of 
SDF-1/CXCR4 axis in CC cell migration to the lungs and 
spleen. High expression of human GAPDH in lungs tissue 
in both control groups of NOD-SCID mice was observed. 
In contrast, CXCR4 receptor downregulation decreased the 
metastatic ability of HTB-35 cells. We observed 12% and 20% 
decrease in metastasis in short- and long-term murine models, 
respectively (Fig. 5D). We also showed that the period of 24 h 
was not sufficient for tumor cells to extravasate into spleen 
tissue. After 30 days of injection, we observed 30% reduction 
in metastasis for shCXCR4 in comparison to control group 
(Fig. 5E). We detected no human cells in the bone marrow 
after injection with HTB-35 cells (data not shown).
Discussion
Growth disorders usually manifest by excessive proliferation 
which cause e.g., rapid primary tumor growth and subsequently 
its invasion and metastasis (23). The role of the chemokine 
receptor CXCR4 in the regulation of tumor growth has been 
recognized as an important issue. In HTB-35 cell line, CXCR4 
downregulation did not change the mitochondrial activity and 
growth potential in vitro. Interestingly, we observed a signifi-
cant decrease in primary tumor growth and weight in vivo. It is 
possible that the CXCR4 receptor is required for the initiation 
Figure 3. The influence of CXCR4 gene downregulation of the expression of genes related with metastasis and angiogenesis at mRNA level. Reduced level 
of MMP-9 was observed in shCXCR4 cell line. The TIMP-2, HIF-1α and VEGF levels were not changed according to CXCR4 gene expression. The mRNA 
expression level was normalized to the human housekeeping gene GAPDH. The experiments were performed two times in duplicate. Data are present as % of 
control cells (WT, wild-type).
Figure 4. The influence of CXCR4 gene downregulation on mitochondrial activity of HTB-35 cell line in vitro. Cells were cultured in medium supplemented 
with 10% FBS or 0.5% BSA. MTS test was performed at 24, 48, 72 and 96 h. We observed no differences between the examined cell lines regardless of standard 
or starvation condition. The experiment was carried out three times in triplicates. Data are presented as mean optical density (OD) ± SD at the appropriate time.
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of cell proliferation and/or promotes the survival of cervical 
cancer cells, similarly to breast cancer cells (24). The observed 
effect of limiting growth in vivo might be explained by low 
expression of CXCR4 which is associated with induction of 
apoptosis and/or a decrease level of proliferation potential 
(24). In addition, Ki-67 staining was performed to check the 
proliferation activity of tumor cells in vivo. Ki-67 antigen is 
expressed from late G1 to the M phase. It has a prognostic 
value and its high level is associated with poor prognosis and 
short patient survival (25). In this study, we observed that a 
decrease of proliferation activity in primary tumors formed 
by shCXCR4 cells, was associated with the reduction of Ki-67 
level. Similar data were reported for breast and lung cancer, 
where increased growth was directly related to Ki-67 upregul-
ation and provides enhanced risk of metastasis (26,27).
Our data define the CXCR4 receptor as a very impor-
tant factor in the metastatic process of cervical cancer. 
Morphological diversity is a common feature of cancer cells 
and might be associated with the ability to generate colonies 
and self-renewal population from single cell (11,28-30). The 
study of CSCs and the mechanisms that regulate their biology 
is challenging. CSCs constitute a small percentage of the tumor 
population. However, we are still unable to define precisely 
markers of these cells for many types of tumors. One possible 
pre-selection of epithelial cells as stem cells is to assess their 
clonogenic potential (11,28). Such cells are capable of forming 
specific clones of different morphology which is an indicator 
of their properties (29). There are: i) holoclones, the structure 
typical for epithelial cells, composed of small, closely adjacent 
cells with increased capacity for self-renewal and differenti-
ation properties, ii) paraclones, the structure formed by the 
cells with irregular shape, loosely arranged in the clone with 
a high degree of differentiation capacity and iii) meroclones, 
intermediate forms of clones (28,30). Among holoclones, 
there is the greatest probability of stem cell presence [e.g. 
keratinocytes (31)] or CSCs [e.g. prostate cancer (29)]. Only 
cells derived from holoclones are able to initiate tumor 
development after transplantation into mice. Furthermore, 
they express surface markers characteristic of CSCs (such as 
CXCR4 and CD44). Interestingly, meroclone-derived cells 
are not able to form tumor tissue. Furthermore, paraclone-
derived cells die during the in vitro culture (29) which was 
also observed in our study in suspension culture. Our results 
indicate that CXCR4/SDF-1 axis play a very important role in 
Figure 5. The influence of CXCR4 gene downregulation on tumor growth in vivo in a murine model. Subcutaneus injection of 5x106 cells/mouse resulted in 
reduced tumor weight (A) and proliferation potential (B) in shCXCR4 cells compared to control cells (WT and shCONTROL). The reduction of Ki-67 antigen, as 
a prolifer ation marker, was detected in shCXCR4 primary tumor tissue with no simultaneous changes in H&E staining (C). Intravenous injection of 1x106 cells/
mouse resulted in decreased hGAPDH/mGAPDH ratio in lung tisssue in short- and long-term murine models of about 12 and 20%, respectively in shCXCR4 
group compared to control group (D). Time of 24 h was not sufficient to populate the spleen tissue of tumor cells, but after 30 days, 30% reduction of hGAPDH/
mGAPDH ratio was associated with CXCR4 downregulation (E). The experiment was performed two times. The total number of mice was 10 per each group.
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maintaining the metastatic potential. Morphological diversity 
showed that CXCR4 downregulation caused the reduction of 
ʻholocloneʼ-like structures possibly indicating a decreased 
number of CSCs. However, further analysis and characteriza-
tion of colonies formed by HTB-35 cells are required, but these 
results reflect a decreased metastatic potential to the lung and 
spleen tissue in the shCXCR4 cell line. Our results are consis-
tent with a study of human breast cancer that also demonstrated 
the importance of CXCR4/SDF-1 signaling at the primary 
tumor microenvironment (32). It is possible that SDF-1 in 
the tumor microenvironment promotes breast cancer prolif-
eration, migration and invasion. The impairment of CXCR4 
and/or SDF-1 activity could interrupt this paracrine signaling 
pathway reducing growth potential of primary tumors (24,32). 
As previously described, CXCR4 receptor is also related to 
bone marrow metastasis in e.g. rhabdomyosarcoma (33), and 
breast cancer (34). Our observation indicates the attenuation 
of AKT and MAPK pathways and inhibition of chemotaxis to 
the SDF-1 gradient in shCXCR4 cells. It may suggest a similar 
mechanism of CXCR4/SDF-1 axis in the cervical cancer cells 
as in the breast cancer and rhabdomyosarcoma (9,24,33).
High level of MMP expression is directly associated with 
tumor invasiveness and poor prognosis (35-37). We observed 
positive relationship between CXCR4 and MMP-9 level in 
HTB-35 cell line. Significant decrease of MMP-9 mRNA 
expression level in the shCXCR4 cells might be associated 
with reduced capacity to form lung and spleen metastasis. 
Surprisingly, the level of HIF-1α and VEGF was not changed. 
The obtained results are different from studies of breast cancer 
angiogenesis. It has been showed that HIF-1α is a potent inducer 
of VEGF but the expression of VEGF can be unregulated via 
HIF-1α independent mechanisms as well (38). It is related to 
the activation of PI3K/AKT pathway, which can be stimulated, 
for example, by CXCR4/SDF-1 interaction. The inhibition of 
this axis significantly decreases the VEGF expression and 
angiogenesis in MDA-MB-231 cells (39).
Inhibition of CXCR4 expression and function signifi-
cantly impairs the growth potential of the HTB-35 cervical 
carcinoma cell line in vivo and efficiently decreases the lung 
and spleen metastasis in an animal NOD-SCID model. Thus, 
our data suggest CXCR4 as a novel target for prevention of 
cervical carcinoma growth and metastasis.
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